Complications and surgery in the inflammatory bowel diseases biological era. - Archive ouverte HAL
Article Dans Une Revue Current Opinion in Gastroenterology Année : 2014

Complications and surgery in the inflammatory bowel diseases biological era.

Résumé

PURPOSE OF REVIEW: Therapy for inflammatory bowel diseases (IBD) has changed dramatically in recent years with a wider use of immunomodulators and the introduction of antitumor necrosis factor (anti-TNF) agents. This article reviews the existing data on the long-term efficacy of biologics, that is, anti-TNF agents, for preventing complications and surgery in patients with IBD. RECENT FINDINGS: Anti-TNF agents are effective for preventing endoscopic and surgical recurrence after surgery for Crohn's disease. They are able to achieve fistula closure and do not increase the risk of stricture. Most randomized short-term trials also showed decreased requirement for hospitalizations and surgery in patients receiving anti-TNF. However, observational studies from referral centers or based on population have shown conflicting results. The need for surgery in Crohn's disease and the risk of colectomy in ulcerative colitis seem to be decreasing in recent years, but the specific effect of the introduction of anti-TNF agents cannot be currently evaluated. SUMMARY: Although anti-TNF agents are the most powerful drugs in IBD, their ability to decrease the need for surgery remains unclear. Conflicting results observed in observational surveys might be because of anti-TNF agents administered too late in the course of IBD.

Domaines

Chimie organique
Fichier non déposé

Dates et versions

hal-00994174 , version 1 (21-05-2014)

Identifiants

Citer

Harry Sokol, Philippe Seksik, Jacques Cosnes. Complications and surgery in the inflammatory bowel diseases biological era.. Current Opinion in Gastroenterology, 2014, 30 (4), pp.378-384. ⟨10.1097/MOG.0000000000000078⟩. ⟨hal-00994174⟩
70 Consultations
0 Téléchargements

Altmetric

Partager

More